Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ames

Showing results (351-360 of 416) with videos related to

Pageof 42
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology GroupSuman Malempati, H Stacy Nicholson, Joel M Reid, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2008
Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomicsNeslihan Aygun Kocabas, Pinar Aksoy, Linda L Pelleymounter, et al.
Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Biochemical Pharmacology|October 6, 1999
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agentD L Walker, J M Reid, P A Svingen, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Ecology and Evolution|October 19, 2020
Bergmann's rule is followed at multiple stages of postembryonic development in a long-distance migratory songbirdJoseph Youtz, Kelly D Miller, Emerson K Bowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium reportMaryam Fouladi, Julie R Park, Clinton F Stewart, et al.
Pediatric Blood & Cancer|March 26, 2014
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group studyMaryam Fouladi, John P Perentesis, Christine L Phillips, et al.
Toxicologic Pathology|October 3, 2014
Characterization of Batracylin-induced Renal and Bladder Toxicity in RatsMyrtle Davis, Deborah I Bunin, Steven J Samuelsson, et al.
Pageof 42

Showing results (351-360 of 416) with videos related to

Sort By:
Pageof 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology GroupSuman Malempati, H Stacy Nicholson, Joel M Reid, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2008
Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomicsNeslihan Aygun Kocabas, Pinar Aksoy, Linda L Pelleymounter, et al.
Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Biochemical Pharmacology|October 6, 1999
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agentD L Walker, J M Reid, P A Svingen, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Ecology and Evolution|October 19, 2020
Bergmann's rule is followed at multiple stages of postembryonic development in a long-distance migratory songbirdJoseph Youtz, Kelly D Miller, Emerson K Bowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium reportMaryam Fouladi, Julie R Park, Clinton F Stewart, et al.
Pediatric Blood & Cancer|March 26, 2014
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group studyMaryam Fouladi, John P Perentesis, Christine L Phillips, et al.
Toxicologic Pathology|October 3, 2014
Characterization of Batracylin-induced Renal and Bladder Toxicity in RatsMyrtle Davis, Deborah I Bunin, Steven J Samuelsson, et al.
Pageof 42